๐ŸŽ Black Friday: up to 50% off of annual plans
Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
53.00
-1.50 (-2.75%)
Nov 20, 2026, 1:30 PM CST

TPE:1720 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7,2307,0236,7896,2405,8514,604
Revenue Growth
4.62%3.44%8.81%6.64%27.09%6.94%
Gross Profit
3,1582,9092,9892,7252,4882,068
Operating Income
1,5861,3631,3971,2601,118876.83
Net Income
1,002927.66880.5834.89815.41706.73
Earnings Per Share
5.094.714.474.254.153.59
EPS Growth
12.07%5.29%5.35%2.41%15.45%34.81%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Human medicine
3,6183,3143,1892,9512,6022,589
Food
2,1662,3072,1822,0262,0571,664
Active Pharmaceutical Ingredient
1,3951,3761,3781,1801,072-
Others
356.38319.65314.2349.74391.23527.56
Revenue from internal divisions
-305.42-293.95-273.44-266.89-270.7-176.49
Total
7,2307,0236,7896,2405,8514,604

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,1642,3851,8042,2682,4802,757
Total Debt
763.52948.82560.431,3281,7901,668
Net Cash (Debt)
1,4011,4361,244939.65689.981,089
Net Cash Growth
23.60%15.49%32.34%36.19%-36.65%56.47%
Net Cash Per Share
7.127.306.324.783.515.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7441,7671,6951,3371,228827.03
Capital Expenditures
-492.4-492.87-596.48-625.7-1,196-213.48
Free Cash Flow
1,2521,2741,098710.8331.78613.56
Free Cash Flow Growth
6.54%15.98%54.53%2136.85%-94.82%7.63%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.68%41.42%44.02%43.68%42.51%44.91%
Operating Margin
21.94%19.41%20.57%20.19%19.11%19.05%
Pretax Margin
23.67%21.56%23.97%23.04%23.92%22.02%
Profit Margin
13.86%13.21%12.97%13.38%13.94%15.35%
FCF Margin
17.31%18.14%16.18%11.39%0.54%13.33%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.8181.8182.5462.4542.2732.273
Dividend Per Share Growth
-21.43%-28.57%3.71%8.00%0%38.88%
Dividend Yield
3.43%3.40%4.52%4.10%4.06%5.80%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.4111.3512.5614.1113.4810.90
Forward PE
-11.4612.7511.8311.8314.74
P/FCF Ratio
7.578.2610.0716.57345.8312.55
PS Ratio
1.311.501.631.891.881.67